Reata Pharmaceuticals Probability of Future Stock Price Finishing Over 109.67
| RETADelisted Stock | USD 109.67 3.31 2.93% |
Reata |
Reata Pharmaceuticals Target Price Odds to finish over 109.67
The tendency of Reata Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 109.67 | 90 days | 109.67 | about 7.94 |
Based on a normal probability distribution, the odds of Reata Pharmaceuticals to move above the current price in 90 days from now is about 7.94 (This Reata Pharmaceuticals probability density function shows the probability of Reata Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Reata Pharmaceuticals has a beta of -0.13 indicating as returns on the benchmark increase, returns on holding Reata Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Reata Pharmaceuticals is likely to outperform the market. Additionally Reata Pharmaceuticals has an alpha of 0.2114, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Reata Pharmaceuticals Price Density |
| Price |
Predictive Modules for Reata Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reata Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reata Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Reata Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Reata Pharmaceuticals is not an exception. The market had few large corrections towards the Reata Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Reata Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Reata Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 8.56 | |
Ir | Information ratio | 0.02 |
Reata Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Reata Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Reata Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Reata Pharmaceuticals is not yet fully synchronised with the market data | |
| Reata Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.22 M. Net Loss for the year was (311.9 M) with loss before overhead, payroll, taxes, and interest of (167.63 M). | |
| Reata Pharmaceuticals currently holds about 481.47 M in cash with (204.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.19. | |
| Over 88.0% of the company shares are owned by institutional investors |
Reata Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Reata Stock often depends not only on the future outlook of the current and potential Reata Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reata Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.3 M | |
| Cash And Short Term Investments | 387.5 M |
Reata Pharmaceuticals Technical Analysis
Reata Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Reata Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Reata Pharmaceuticals. In general, you should focus on analyzing Reata Stock price patterns and their correlations with different microeconomic environments and drivers.
Reata Pharmaceuticals Predictive Forecast Models
Reata Pharmaceuticals' time-series forecasting models is one of many Reata Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Reata Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Reata Pharmaceuticals
Checking the ongoing alerts about Reata Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Reata Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Reata Pharmaceuticals is not yet fully synchronised with the market data | |
| Reata Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.22 M. Net Loss for the year was (311.9 M) with loss before overhead, payroll, taxes, and interest of (167.63 M). | |
| Reata Pharmaceuticals currently holds about 481.47 M in cash with (204.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.19. | |
| Over 88.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world |